I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Lisa Bacus Biography and Net Worth

EVP of The Cigna Group

Lisa R. Bacus serves as Independent Director of the Company. Ms. Bacus served as the Executive Vice President and Chief Marketing Officer at Cigna Corporation, a global health care services company, from May 2013 until her retirement in July 2019. Her marketing role expanded with Cigna’s acquisition of Express Scripts in December 2018. Prior to joining Cigna, Ms. Bacus was the Executive Vice President and chief marketer at American Family Insurance Group, a personal and commercial property and casualty company, from 2011 until 2013, and its Vice President, Marketing, from 2008 to 2011. Before joining American Family Insurance, she was with Ford Motor Company, from 1986 to 2008, where she held a number of executive leadership positions, including Executive Director of Global Market Research and Insights, Executive Director of Global Marketing Strategy, and head of marketing for Ford in Mexico. She serves on the board of privately-held Culver Franchising System, Inc., as well as a number of non-profit corporations, and previously served on the board of Shoutlet, Inc., a privately-held company. Ms. Bacus joined our board in January 2015.

What is Lisa R. Bacus' net worth?: The estimated net worth of Lisa R. Bacus is at least $7.39 million as of March 14th, 2019. Ms. Bacus owns 22,486 shares of The Cigna Group stock worth more than $7,385,527 as of November 23rd. This net worth approximation does not reflect any other investments that Ms. Bacus may own. Learn More about Lisa R. Bacus' net worth.
How do I contact Lisa R. Bacus?: The corporate mailing address for Ms. Bacus and other The Cigna Group executives is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The Cigna Group can also be reached via phone at (860) 226-6000 and via email at [email protected]. Learn More on Lisa R. Bacus' contact information.
Has Lisa R. Bacus been buying or selling shares of The Cigna Group?: Lisa R. Bacus has not been actively trading shares of The Cigna Group during the past quarter. Most recently, Lisa R. Bacus sold 2,236 shares of the business's stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $179.95, for a transaction totalling $402,368.20. Following the completion of the sale, the executive vice president now directly owns 18,501 shares of the company's stock, valued at $3,329,254.95. Learn More on Lisa R. Bacus' trading history.
Who are The Cigna Group's active insiders?: The Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (President, CEO & Chairman of the Board), William DeLaney, III (Director), Noelle Eder (EVP and Global Chief Information Officer), Brian Evanko (CFO), Brian Evanko (Exec. VP & CFO ), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (Insider), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on The Cigna Group's active insiders.
Are insiders buying or selling shares of The Cigna Group?: During the last year, insiders at the health services provider sold shares 17 times. They sold a total of 139,823 shares worth more than $48,194,208.52. The most recent insider tranaction occured on August, 19th when Director William J Delaney III sold 2,691 shares worth more than $922,151.88. Insiders at The Cigna Group own 0.6% of the company. Learn More about insider trades at The Cigna Group.
Information on this page was last updated on 8/19/2024.

Lisa R. Bacus Insider Trading History at The Cigna Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/16/2017	Sell	2,236	$179.95	$402,368.20	18,501
5/24/2017	Sell	11,455	$161.57	$1,850,784.35	24,753

Lisa R. Bacus Buying and Selling Activity at The Cigna Group

The Cigna Group Company Overview

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Today's Range

Now: $328.45

$325.47

$330.94

50 Day Range

MA: $335.43

$308.23

$367.07

2 Week Range

Now: $328.45

$253.95

$370.83

Volume

1,475,200 shs

Average Volume

1,961,775 shs

Market Capitalization

$91.36 billion

P/E Ratio

30.99

Dividend Yield

1.70%

Beta

0.51

I was wrong. Dead wrong.

From Porter & Company | Ad